www.varchev.com

Highly positive sentiment before US opening. Where is the profits today?

Positive sentiment on NYSE

Rating:

12345
Loading...

US futures indicate a positive start for overseas markets. Dow Jones futures grew by 43 points and SP500 and NASDAQ by 5 and 13 points respectively. Investors note North Korea's desire to resume diplomacy with South Korea and the introduction of new EU regulations that will make the stock market more transparent. On the other hand, FED raised interest rates in December and prospects for the US economy. After the holidays, during which investors were cautious, trading volumes increased and the market reflected positively the "bright future" of the US economy.

Who will be the biggest winners and which share to target after opening the market?

1. Alibaba - once it became clear that the company would not acquire Money Gram, $ 1.2bn remain available, and investors have a strong positive effect on this. Given the highly positive market, we expect the growth to continue and if not today, we will see a new record for the company's price in the coming days. The company traded 0.70% increase.

2. IBM - The company received a better market estimate and one-year RBC Capital target jumped to $ 180 from $ 160. The company shares are traded at 1.41%.

3. American Express - Deutsche Bank changed its recommendation for American Express to "buy", noting the benefits of tax reform and the reduction of federal regulation. The company did not change the price at the drop-off. In the long run, we expect the company to continue its growth.

4. Oracle - Morgan Stanley said the company was greatly underestimated after the company's latest disappointing financial results. At the discount, the company traded with a 1.44% increase, and the short-term trend adjustment gives us a good chance for Long with low risk.

Jr Trader Petar Milanov


 Varchev Traders

Read more:

RECCOMEND WAS THIS POST USEFUL FOR YOU?
If you think, we can improve that section,
please comment. Your oppinion is imortant for us.
WARNING: Any news, opinions, research, data or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. Varchev Finance Ltd. expressly disclaims any liability for any lost principal or profits which may arise directly or indirectly from the use of or reliance on such information. Varchev Finance Ltd. may provide information, quotes, references and links to or from other sites and blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the sites, blogs or other sources of information.
Varchev Finance

London


25 Canada Square, Level 33, office 50, Canary Wharf London, E14 5LQ +44 20 3608 6256

Universal numbers

World Financial Markets - 0700 17 600    Varchev Exchange - 0700 115 44

Varchev Finance Ltd is registered in the FCA (FINANCIAL CONDUCT AUTHORITY) with a passport in the United Kingdom: FCA, United Kingdom - registration number: 494 045, which allows provision of financial services in the United Kingdom.

Varchev Finance Ltd strictly comply with the statutes of the European directive MiFID (Markets in Financial Instruments). targeting increased efficiency, transparency and uniformity of financial instruments.
Varchev Finance Ltd is authorized and regulated by the Financial Supervision Commission - Sofia, Bulgaria: License number RG-03-02-05 / 15.03.2006

The information on this site is not intended for distribution or use by any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.


Disclaimer:

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 63,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.

chat with dealer
chat with dealer
Cookies policy